Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method of treatment or prophylaxis of symptoms of herpes viral infection

A technology for herpes virus infection and cold sore, which can be used in antiviral agents, pharmaceutical formulations, medical preparations containing active ingredients, etc., and can solve problems such as ineffective treatment

Inactive Publication Date: 2006-03-22
PENAM INVESTMENTS PTY LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Not all herpes virus infections are sensitive to acyclovir, and in addition, treatment is often ineffective if it is delayed beyond the early stages of infection and symptom development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0037] Sterile injectable solutions are prepared by incorporating the active compound in the required amount in an appropriate solvent with various other ingredients enumerated above, as required, followed by filtered sterilization. In the case of sterile powders for the preparation of sterile injectable solutions, the preferred methods of preparation are vacuum drying and the freeze-drying techniques which yield a powder of the active ingredient plus any additional desired ingredient from a previously sterile-filtered solution thereof.

[0038] The composition can be administered orally, for example, with an inert diluent or an assimilable edible carrier, or it can be enclosed in a hard or soft shell gelatin capsule, or it can be compressed into tablets, or it can be Can be in powder form or added directly to food in the diet. For oral therapeutic and / or prophylactic administration, the active compound may be incorporated into excipients and presented as ingestible tablets, t...

Embodiment 1

[0047] compound

[0048] Patients suffering from cold sores were administered 300 mg of the above composition in capsule form, and their cold sore healing rates relative to control patients were determined.

Embodiment 2

[0050] compound

[0051] Patients suffering from cold sores were administered 300 mg of the above composition in capsule form, and their cold sore healing rates relative to control patients were determined.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method is provided for the treating or prophylaxis of one or more symptoms of viral infection. The method involves the administration of citrate and / or succinate salts. The present invention also encompasses the use of citrate and / or succinate salts for the treatment or prevention of lesions or blisters, or other symptoms of infection by members of the herpes virus family.

Description

field of invention [0001] The present invention generally relates to methods of treating or preventing symptoms of one or more viral infections, more particularly herpes virus infections, in a patient. The invention also encompasses the use of compositions for treating or preventing lesions or blisters or other symptoms caused by members of the Herpesviridae family. Background of the invention [0002] Reference to any prior art in this specification is not and should not be taken as an acknowledgment or any form of suggestion that such prior art is or forms part of the common general knowledge in Australia or any other country. [0003] In this specification, unless the context requires otherwise, the term "comprise" and variations such as "comprises (verb)" and "comprises (gerund)" will be understood to mean including the stated element or whole or step or element or whole or a collection of steps, but does not exclude any other element or whole or step or collection of e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/215A61P31/22
CPCA61K31/215A61P31/22A61K2300/00A61K31/22
Inventor N·麦格雷戈
Owner PENAM INVESTMENTS PTY LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com